Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05347485
Title A Study of JNJ-68284528 Out-of-Specification (OOS) for Commercial Release in Participants With Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Janssen Scientific Affairs, LLC
Indications

multiple myeloma

Therapies

Ciltacabtagene autoleucel

Cyclophosphamide + Fludarabine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.